Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection

Journal of Immunology

Volumn 186, Issue 2, 2011, Pages 745-753

  Nigam, Pragati ^a   Kwa, Suefen ^a   Velu, Vijayakumar ^a   Amara, Rama Rao ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 17; INTERLEUKIN 2; IONOMYCIN; LOPINAVIR PLUS RITONAVIR; TENOFOVIR; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CERCOCEBUS; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUODENUM; ILEUM; JEJUNUM; LENTIVIRUS INFECTION; LYMPHOID TISSUE; MACACA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS INFECTION; SPLEEN; TH17 CELL;

ACUTE DISEASE; ANIMALS; ANTI-RETROVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CERCOCEBUS ATYS; CHRONIC DISEASE; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-17; INTESTINAL MUCOSA; INTESTINE, SMALL; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOPENIA; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS;

EID: 79251549476     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002807     Document Type: Article

References (41)

1. MacDonald, T. T., and S. H. Murch. 1994. Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillieres Clin. Gastroenterol. 8: 1-34.
2. Schieferdecker, H. L., R. Ullrich, H. Hirseland, and M. Zeitz. 1992. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J. Immunol. 149: 2816-2822.
3. Mattapallil, J. J., D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
4. Favre, D., S. Lederer, B. Kanwar, Z. M. Ma, S. Proll, Z. Kasakow, J. Mold, L. Swainson, J. D. Barbour, C. R. Baskin, et al. 2009. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5: e1000295.
5. Veazey, R. S., M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, R. P. Johnson, R. C. Desrosiers, and A. A. Lackner. 1998. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280: 427-431.
6. Heise, C., C. J. Miller, A. Lackner, and S. Dandekar. 1994. Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J. Infect. Dis. 169: 1116-1120.
7. Heise, C., P. Vogel, C. J. Miller, C. H. Halsted, and S. Dandekar. 1993. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am. J. Pathol. 142: 1759-1771.
8. Batman, P. A., A. R. Miller, S. M. Forster, J. R. Harris, A. J. Pinching, and G. E. Griffin. 1989. Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J. Clin. Pathol. 42: 275-281.
9. Ullrich, R., M. Zeitz, W. Heise, M. L'age, G. Höffken, and E. O. Riecken. 1989. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann. Intern. Med. 111: 15-21.
10. Cummins, A. G., J. T. LaBrooy, D. P. Stanley, R. Rowland, and D. J. Shearman. 1990. Quantitative histological study of enteropathy associated with HIV infection. Gut 31: 317-321.
11. MacDonald, T. T., and J. Spencer. 1992. Cell-mediated immune injury in the intestine. Gastroenterol. Clin. North Am. 21: 367-386.
12. Clayburgh, D. R., L. Shen, and J. R. Turner. 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84: 282-291.
13. George, M. D., J. Wehkamp, R. J. Kays, C. M. Leutenegger, S. Sabir, I. Grishina, S. Dandekar, and C. L. Bevins. 2008. In vivo gene expression profiling of human intestinal epithelial cells: analysis by laser microdissection of formalin fixed tissues. BMC Genomics 9: 209.
14. Sankaran, S., M. D. George, E. Reay, M. Guadalupe, J. Flamm, T. Prindiville, and S. Dandekar. 2008. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol. 82: 538-545.
15. Sankaran, S., M. Guadalupe, E. Reay, M. D. George, J. Flamm, T. Prindiville, and S. Dandekar. 2005. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc. Natl. Acad. Sci. USA 102: 9860-9865.
16. Abel, K., D. M. Rocke, B. Chohan, L. Fritts, and C. J. Miller. 2005. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J. Virol. 79: 12164-12172.
17. Reka, S., M. L. Garro, and D. P. Kotler. 1994. Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection. Lymphokine Cytokine Res. 13: 391-398.
18. Olsson, J., M. Poles, A. L. Spetz, J. Elliott, L. Hultin, J. Giorgi, J. Andersson, and P. Anton. 2000. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J. Infect. Dis. 182: 1625-1635.
19. McGowan, I., J. Elliott, M. Fuerst, P. Taing, J. Boscardin, M. Poles, and P. Anton. 2004. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J. Acquir. Immune Defic. Syndr. 37: 1228-1236.
20. Nazli, A., O. Chan, W. N. Dobson-Belaire, M. Ouellet, M. J. Tremblay, S. D. Gray-Owen, A. L. Arsenault, and C. Kaushic. 2010. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 6: e1000852.
21. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371.
22. Brenchley, J. M., D. A. Price, and D. C. Douek. 2006. HIV disease: fallout from a mucosal catastrophe? Nat. Immunol. 7: 235-239.
23. Brenchley, J. M., M. Paiardini, K. S. Knox, A. I. Asher, B. Cervasi, T. E. Asher, P. Scheinberg, D. A. Price, C. A. Hage, L. M. Kholi, et al. 2008. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112: 2826-2835.
24. Cecchinato, V., C. J. Trindade, A. Laurence, J. M. Heraud, J. M. Brenchley, M. G. Ferrari, L. Zaffiri, E. Tryniszewska, W. P. Tsai, M. Vaccari, et al. 2008. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 1: 279-288.
25. Raffatellu, M., R. L. Santos, D. E. Verhoeven, M. D. George, R. P. Wilson, S. E. Winter, I. Godinez, S. Sankaran, T. A. Paixao, M. A. Gordon, et al. 2008. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14: 421-428.
26. Yen, H. R., T. J. Harris, S. Wada, J. F. Grosso, D. Getnet, M. V. Goldberg, K. L. Liang, T. C. Bruno, K. J. Pyle, S. L. Chan, et al. 2009. Tc17 CD8 T cells: functional plasticity and subset diversity. J. Immunol. 183: 7161-7168.
27. Zhao, Y., A. Balato, R. Fishelevich, A. Chapoval, D. L. Mann, and A. A. Gaspari. 2009. Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis. Br. J. Dermatol. 161: 1301-1306.
28. Huber, M., S. Heink, H. Grothe, A. Guralnik, K. Reinhard, K. Elflein, T. Hünig, H. W. Mittrücker, A. Brüstle, T. Kamradt, and M. Lohoff. 2009. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur. J. Immunol. 39: 1716-1725.
29. Ciric, B., M. El-behi, R. Cabrera, G. X. Zhang, and A. Rostami. 2009. IL-23 drives pathogenic IL-17-producing CD8+ T cells. J. Immunol. 182: 5296-5305.
30. Hamada, H., Mde. L. Garcia-Hernandez, J. B. Reome, S. K. Misra, T. M. Strutt, K. K. McKinstry, A. M. Cooper, S. L. Swain, and R. W. Dutton. 2009. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J. Immunol. 182: 3469-3481.
31. Kondo, T., H. Takata, F. Matsuki, and M. Takiguchi. 2009. Cutting edge: phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J. Immunol. 182: 1794-1798.
32. Klatt, N. R., L. D. Harris, C. L. Vinton, H. Sung, J. A. Briant, B. Tabb, D. Morcock, J. W. McGinty, J. D. Lifson, B. A. Lafont, et al. 2010. Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol. 3: 387-398.
33. Kader, M., S. Bixler, M. Piatak, J. Lifson, and J. J. Mattapallil. 2009. Antiretroviral therapy fails to restore the severe Th-17: Tc-17 imbalance observed in peripheral blood during simian immunodeficiency virus infection. J. Med. Primatol. 38(Suppl 1): 32-38.
34. Amara, R. R., J. M. Smith, S. I. Staprans, D. C. Montefiori, F. Villinger, J. D. Altman, S. P. O'Neil, N. L. Kozyr, Y. Xu, L. S. Wyatt, et al. 2002. Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine. J. Virol. 76: 6138-6146.
35. Velu, V., S. Kannanganat, C. Ibegbu, L. Chennareddi, F. Villinger, G. J. Freeman, R. Ahmed, and R. R. Amara. 2007. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. J. Virol. 81: 5819-5828.
36. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, et al. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292: 69-74.
37. Lewis, K., and D. M. McKay. 2009. Metabolic stress evokes decreases in epithelial barrier function. Ann. N. Y. Acad. Sci. 1165: 327-337.
38. Schmitz, H., M. Fromm, C. J. Bentzel, P. Scholz, K. Detjen, J. Mankertz, H. Bode, H. J. Epple, E. O. Riecken, and J. D. Schulzke. 1999. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 112: 137-146.
39. Kader, M., X. Wang, M. Piatak, J. Lifson, M. Roederer, R. Veazey, and J. J. Mattapallil. 2009. Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol. 2: 439-449.
40. Parry, R. V., J. M. Chemnitz, K. A. Frauwirth, A. R. Lanfranco, I. Braunstein, S. V. Kobayashi, P. S. Linsley, C. B. Thompson, and J. L. Riley. 2005. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25: 9543-9553.
41. Iannello, A., M. R. Boulassel, S. Samarani, O. Debbeche, C. Tremblay, E. Toma, J. P. Routy, and A. Ahmad. 2010. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J. Immunol. 184: 114-126.